Good price  online

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Breast Cancer Drugs
Created with Pixso. Palbociclib Capsules 125mg 21 Capsules Box Standard Dose CDK4 6 Inhibitor First Line Endocrine Therapy Advanced Breast Cancer

Palbociclib Capsules 125mg 21 Capsules Box Standard Dose CDK4 6 Inhibitor First Line Endocrine Therapy Advanced Breast Cancer

Brand Name: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Number: Palbociclib KL-20223934
MOQ: Negotiable
Price: Please contact a specialist WhatsApp:55342706
Delivery Time: Negotiable
Payment Terms: Western Union, MoneyGram, T/T
Detail Information
Place of Origin:
Chengdu, Sichuan, China
Certification:
NMPA/GMP
Packaging Details:
Negotiable
Supply Ability:
Negotiable
Highlight:

Standard Dose CDK4 6 Inhibitor

,

First Line Metastatic Breast Cancer

,

Palbociclib Letrozole Combination

Product Description

Palbociclib 125mg x 21 Capsules

[Product Name]

Generic Name: Palbociclib

Brand Name: Pailunxin

Specification: 125mg x 21 Capsules

[Active Ingredient]

Palbociclib

[Indications]

HR+/HER2- advanced/metastatic breast cancer: first-line with aromatase inhibitor; post-endocrine with fulvestrant. Standard starting dose.

[Mechanism of Action]

First-in-class highly selective CDK4/6 inhibitor. Prevents Rb phosphorylation, inducing G1 cell cycle arrest.

[Dosage]

125mg daily with food, 21 days on/7 off. Reduce to 100mg or 75mg for toxicity.

[Adverse Reactions]

Neutropenia G3-4 (66%), leukopenia, infections, fatigue, nausea, stomatitis, anemia, alopecia. Febrile neutropenia (2%), PE (2-5%).

[Storage]

Store below 30C. Keep out of reach of children.

[Shelf Life]

24 months

Approval: H20223934